Department of Neurosurgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany.
JAMA Neurol. 2023 Aug 1;80(8):833-842. doi: 10.1001/jamaneurol.2023.1792.
After aneurysmal subarachnoid hemorrhage, the use of lumbar drains has been suggested to decrease the incidence of delayed cerebral ischemia and improve long-term outcome.
To determine the effectiveness of early lumbar cerebrospinal fluid drainage added to standard of care in patients after aneurysmal subarachnoid hemorrhage.
DESIGN, SETTING, AND PARTICIPANTS: The EARLYDRAIN trial was a pragmatic, multicenter, parallel-group, open-label randomized clinical trial with blinded end point evaluation conducted at 19 centers in Germany, Switzerland, and Canada. The first patient entered January 31, 2011, and the last on January 24, 2016, after 307 randomizations. Follow-up was completed July 2016. Query and retrieval of data on missing items in the case report forms was completed in September 2020. A total of 20 randomizations were invalid, the main reason being lack of informed consent. No participants meeting all inclusion and exclusion criteria were excluded from the intention-to-treat analysis. Exclusion of patients was only performed in per-protocol sensitivity analysis. A total of 287 adult patients with acute aneurysmal subarachnoid hemorrhage of all clinical grades were analyzable. Aneurysm treatment with clipping or coiling was performed within 48 hours.
A total of 144 patients were randomized to receive an additional lumbar drain after aneurysm treatment and 143 patients to standard of care only. Early lumbar drainage with 5 mL per hour was started within 72 hours of the subarachnoid hemorrhage.
Primary outcome was the rate of unfavorable outcome, defined as modified Rankin Scale score of 3 to 6 (range, 0 to 6), obtained by masked assessors 6 months after hemorrhage.
Of 287 included patients, 197 (68.6%) were female, and the median (IQR) age was 55 (48-63) years. Lumbar drainage started at a median (IQR) of day 2 (1-2) after aneurysmal subarachnoid hemorrhage. At 6 months, 47 patients (32.6%) in the lumbar drain group and 64 patients (44.8%) in the standard of care group had an unfavorable neurological outcome (risk ratio, 0.73; 95% CI, 0.52 to 0.98; absolute risk difference, -0.12; 95% CI, -0.23 to -0.01; P = .04). Patients treated with a lumbar drain had fewer secondary infarctions at discharge (41 patients [28.5%] vs 57 patients [39.9%]; risk ratio, 0.71; 95% CI, 0.49 to 0.99; absolute risk difference, -0.11; 95% CI, -0.22 to 0; P = .04).
In this trial, prophylactic lumbar drainage after aneurysmal subarachnoid hemorrhage lessened the burden of secondary infarction and decreased the rate of unfavorable outcome at 6 months. These findings support the use of lumbar drains after aneurysmal subarachnoid hemorrhage.
ClinicalTrials.gov Identifier: NCT01258257.
蛛网膜下腔出血后,建议使用腰椎引流以降低迟发性脑缺血的发生率并改善长期预后。
确定在蛛网膜下腔出血患者中,早期添加标准治疗的腰椎脑脊液引流的有效性。
设计、设置和参与者:EARLYDRAIN 试验是一项实用、多中心、平行组、开放性随机临床试验,在德国、瑞士和加拿大的 19 个中心进行,终点评估采用盲法。第一个患者于 2011 年 1 月 31 日入组,最后一个于 2016 年 1 月 24 日入组,共 307 例随机分组。随访于 2016 年 7 月完成。2020 年 9 月完成对病例报告表中缺失项目的数据查询和检索。由于缺乏知情同意,主要原因是 20 次随机分配无效。未从意向治疗分析中排除符合所有纳入和排除标准的患者。仅在方案敏感性分析中排除患者。共 287 例急性蛛网膜下腔出血的成年患者符合所有临床分级标准,可进行分析。在 48 小时内进行夹闭或血管内栓塞治疗动脉瘤。
共有 144 例患者随机接受动脉瘤治疗后附加腰椎引流,143 例患者仅接受标准治疗。蛛网膜下腔出血后 72 小时内,以 5 毫升/小时的速度开始进行腰椎引流。
主要结局为 6 个月时不利结局的发生率,定义为改良Rankin 量表评分为 3 至 6 分(范围 0 至 6 分),由盲法评估者评估。
在纳入的 287 例患者中,197 例(68.6%)为女性,中位(IQR)年龄为 55(48-63)岁。腰椎引流开始于蛛网膜下腔出血后中位数(IQR)第 2 天(1-2)。6 个月时,腰椎引流组 47 例(32.6%)和标准治疗组 64 例(44.8%)患者发生不良神经结局(风险比,0.73;95%CI,0.52 至 0.98;绝对风险差异,-0.12;95%CI,-0.23 至-0.01;P=0.04)。接受腰椎引流治疗的患者出院时的继发性梗死较少(41 例[28.5%]与 57 例[39.9%];风险比,0.71;95%CI,0.49 至 0.99;绝对风险差异,-0.11;95%CI,-0.22 至 0;P=0.04)。
在这项试验中,蛛网膜下腔出血后预防性腰椎引流减轻了继发性梗死的负担,并降低了 6 个月时不良结局的发生率。这些发现支持在蛛网膜下腔出血后使用腰椎引流。
ClinicalTrials.gov 标识符:NCT01258257。